BREAST CANCER

Elevated Interleukin-13 Receptor Alpha 1 Expression in Tumor Cells Is Associated with Poor Prognosis in Patients with Invasive Breast Cancer
https://www.ncbi.nlm.nih.gov/pubmed/28634667

IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition
https://www.ncbi.nlm.nih.gov/pubmed/28400477

IL-4 modulate the tumor microenvironment and response to cancer therapies
http://cancerres.aacrjournals.org/content/76/14_Supplement/1454.short

Targeting IL4/IL4R for the treatment of epithelial cancer metastasis
http://www.ncbi.nlm.nih.gov/pubmed/26385103

Lessons from immunology: IL4R directly promotes mammary tumor metastasis
http://www.ncbi.nlm.nih.gov/pubmed/25941616

IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth
http://www.ncbi.nlm.nih.gov/pubmed/25746764

IL4 receptor ILR4α regulates metastatic colonization by mammary tumors through multiple signaling pathways
http://www.ncbi.nlm.nih.gov/pubmed/24947041

Effect of interleukin (IL)-4 cytotoxin on breast tumor growth after in vivo gene transfer of IL-4 receptor alpha chain
http://www.ncbi.nlm.nih.gov/pubmed/12738741

Human Breast Carcinoma Cells Express Type II IL-4 Receptors and Are Sensitive to Antitumor Activity of a Chimeric IL-4-Pseudomonas Exotoxin Fusion Protein in
vitro and in vivo                  
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1949945/